
Clinical use of GLP-1 agonists and DPP4 inhibitors
Keywords: دیابت نوع 2; Type 2 diabetes; Incretins; Glucagon-like peptide 1; Dipeptidyl peptidase-4 inhibitors; Oral hypoglycaemics; Exocrine pancreatic disease;